IS5078A - Ný efnasambönd með verkjadeyfandi áhrif - Google Patents

Ný efnasambönd með verkjadeyfandi áhrif

Info

Publication number: IS5078A
Authority: IS; Iceland
Prior art keywords: new compounds; analgesic effect; analgesic; effect; compounds
Prior art date: 1996-12-20

Application number

IS5078A

Other languages

English (en)

Inventor

Pelcman Benjamin

Roberts Edward

Original Assignee

Astra Pharma Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1999-06-11

Publication date

1999-06-11

1999-06-11 Application filed by Astra Pharma Inc. filed Critical Astra Pharma Inc.

1999-06-11 Publication of IS5078A publication Critical patent/IS5078A/is

Links

230000000202 analgesic effect Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Optics & Photonics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)

IS5078A 1996-12-20 1999-06-11 Ný efnasambönd með verkjadeyfandi áhrif IS5078A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604786A SE9604786D0 (sv)	1996-12-20	1996-12-20	New compounds
PCT/SE1997/002051 WO1998028270A1 (en)	1996-12-20	1997-12-09	Novel compounds with analgesic effect

Publications (1)

Publication Number	Publication Date
IS5078A true IS5078A (is)	1999-06-11

Family

ID=20405139

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5078A IS5078A (is)	1996-12-20	1999-06-11	Ný efnasambönd með verkjadeyfandi áhrif

Country Status (31)

Country	Link
US (3)	US6153626A (is)
EP (2)	EP0946510B1 (is)
JP (1)	JP2001507021A (is)
KR (1)	KR20000069600A (is)
CN (2)	CN1154635C (is)
AR (1)	AR010378A1 (is)
AT (1)	ATE266638T1 (is)
AU (1)	AU738002B2 (is)
BR (1)	BR9713785A (is)
CA (1)	CA2274117A1 (is)
CZ (1)	CZ220099A3 (is)
DE (1)	DE69729115T2 (is)
DK (1)	DK0946510T3 (is)
EE (1)	EE03966B1 (is)
ES (1)	ES2219783T3 (is)
HU (1)	HUP0000613A3 (is)
ID (1)	ID21662A (is)
IL (1)	IL130536A0 (is)
IS (1)	IS5078A (is)
MY (1)	MY132705A (is)
NO (1)	NO313632B1 (is)
NZ (1)	NZ336028A (is)
PL (1)	PL188945B1 (is)
PT (1)	PT946510E (is)
RU (1)	RU2193030C2 (is)
SE (1)	SE9604786D0 (is)
SK (1)	SK283300B6 (is)
TR (1)	TR199901411T2 (is)
UA (1)	UA54481C2 (is)
WO (1)	WO1998028270A1 (is)
ZA (1)	ZA9711049B (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
TW548271B (en) *	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
US6974825B1 (en)	1996-12-20	2005-12-13	Astrazeneca Canada Inc.	Compounds with analgesic effect
JP4754068B2 (ja) *	1997-12-24	2011-08-24	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類
AU2003220725B2 (en) *	1997-12-24	2006-06-01	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
EP1512683B1 (en) *	1998-03-10	2011-08-31	Research Triangle Institute	Novel opiate compounds, methods of making and methods of use
US6900228B1 (en) *	1998-03-10	2005-05-31	Research Triangle Institute	Opiate compounds, methods of making and methods of use
US6436959B1 (en)	1998-12-23	2002-08-20	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)]aminobenzamides
SE9904675D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904674D0 (sv) *	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904673D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
JP2003518119A (ja) *	1999-12-22	2003-06-03	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	４−［アリール（８−アザビシクロ［３．２．１］オクタン−３−イル）］アミノ安息香酸誘導体
CA2400640A1 (en) *	2000-02-18	2001-08-23	Meiji Seika Kaisha, Ltd.	Phenoxyalkylamine derivatives useful as opioid .delta. receptor ligands
IL151550A0 (en)	2000-03-03	2003-04-10	Ortho Mcneil Pharm Inc	3-(diarylmethylene)-8-azabicyclo [3.2.1] octane derivatives
US6790854B2 (en)	2000-03-24	2004-09-14	Meiji Seika Kaisha, Ltd.	Diphenylalkylamine derivatives useful as opioid receptor agonists
SE0001209D0 (sv)	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
AU2002234010A1 (en) *	2000-12-14	2002-06-24	Ortho-Mcneil Pharmaceutical, Inc.	Benzamidine derivatives
JP2004515539A (ja) *	2000-12-15	2004-05-27	アストラゼネカ・アクチエボラーグ	ジアリール−４−アミノ−ピペリジニル化合物の新しい調製方法
WO2002094794A1 (en)	2001-05-18	2002-11-28	Astrazeneca Ab	4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
SE0101769D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101771D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101773D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101770D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
NZ531679A (en)	2001-10-15	2005-02-25	Janssen Pharmaceutica Nv	Novel substituted 4-phenyl-4-[1H-imidazol-2-YL]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
KR20040090979A (ko) *	2002-03-13	2004-10-27	얀센 파마슈티카 엔.브이.	히스톤 데아세틸레이즈의 신규한 억제제
EP1507756B1 (en)	2002-05-24	2015-07-22	Millennium Pharmaceuticals, Inc.	Ccr9 inhibitors and methods of use thereof
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
US7227035B2 (en)	2002-11-18	2007-06-05	Chemocentryx	Bis-aryl sulfonamides
US7741519B2 (en)	2007-04-23	2010-06-22	Chemocentryx, Inc.	Bis-aryl sulfonamides
DK1798223T4 (da)	2002-11-18	2014-09-22	Chemocentryx Inc	Arylsulfonamider
US7420055B2 (en)	2002-11-18	2008-09-02	Chemocentryx, Inc.	Aryl sulfonamides
US7601740B2 (en) *	2003-01-16	2009-10-13	Acadia Pharmaceuticals, Inc.	Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
UA86024C2 (ru) *	2003-06-27	2009-03-25	Янссен Фармацевтика Н.В.	Трициклические дельта-опиоидные модуляторы
US7435822B2 (en)	2004-02-03	2008-10-14	Janssen Pharmaceutica N.V.	3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
KR101234421B1 (ko)	2004-08-02	2013-02-18	아스트라제네카 아베	디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
CA2574768A1 (en) *	2004-08-05	2006-02-05	Janssen Pharmaceutica N.V.	Tricyclic delta-opioid modulators
US20060135522A1 (en) *	2004-12-22	2006-06-22	Carson John R	Tricyclic delta-opioid modulators
CA2591963A1 (en) *	2004-12-22	2006-06-29	Janssen Pharmaceutica N.V.	Tricyclic o-opioid modulators
US7589104B2 (en) *	2004-12-22	2009-09-15	Janssen Pharmaceutica Nv	Tricyclic-bridged piperidinyline derivatives as §-opioid modulators
JP2008526878A (ja) *	2005-01-06	2008-07-24	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	三環式δ−オピオイド調節剤
TWI449692B (zh) *	2005-05-13	2014-08-21	Otsuka Pharma Co Ltd	吡咯烷化合物（三）
DE602006018604D1 (de) *	2005-06-16	2011-01-13	Janssen Pharmaceutica Nv	Tricyclische opioidmodulatoren
JP5219465B2 (ja) *	2006-11-10	2013-06-26	大塚製薬株式会社	医薬

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4091096A (en) *	1976-03-19	1978-05-23	Eli Lilly And Company	Dinitroanilines for the control of phytopathogens
EG12406A (en) *	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE441448B (sv) *	1977-05-23	1985-10-07	Pfizer	Sett att framstella hexahydro-gamma-karbolinforeningar
DE3200304A1 (de) *	1981-01-16	1982-08-26	Sandoz-Patent-GmbH, 7850 Lörrach	3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3563964D1 (en) *	1984-10-16	1988-09-01	Synthelabo	Piperidine derivatives, their preparation and their therapeutical application
KR940003491B1 (ko)	1989-08-10	1994-04-23	리히터 게데온 베기에스제티 기아르 알.티	4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
YU150489A (sh)	1989-08-10	1992-12-21	W.L. Gore & Co. Gmbh.	Uređaj za ispitivanje odevnih predmeta na nepromočivost
SE8904298D0 (sv) *	1989-12-21	1989-12-21	Astra Ab	New compounds
GB9202238D0 (en) *	1992-02-03	1992-03-18	Wellcome Found	Compounds
US5854245A (en) *	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
SE9604786D0 (sv)	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
TW548271B (en) *	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
JP4754068B2 (ja) *	1997-12-24	2011-08-24	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類
EP1512683B1 (en)	1998-03-10	2011-08-31	Research Triangle Institute	Novel opiate compounds, methods of making and methods of use
US6436959B1 (en)	1998-12-23	2002-08-20	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)]aminobenzamides

1996
- 1996-12-20 SE SE9604786A patent/SE9604786D0/xx unknown
1997
- 1997-09-12 UA UA99074131A patent/UA54481C2/uk unknown
- 1997-12-09 BR BR9713785-5A patent/BR9713785A/pt unknown
- 1997-12-09 DK DK97950539T patent/DK0946510T3/da active
- 1997-12-09 CZ CZ992200A patent/CZ220099A3/cs unknown
- 1997-12-09 AU AU53513/98A patent/AU738002B2/en not_active Ceased
- 1997-12-09 NZ NZ336028A patent/NZ336028A/en unknown
- 1997-12-09 TR TR1999/01411T patent/TR199901411T2/xx unknown
- 1997-12-09 AT AT97950539T patent/ATE266638T1/de not_active IP Right Cessation
- 1997-12-09 ZA ZA9711049A patent/ZA9711049B/xx unknown
- 1997-12-09 RU RU99115746/04A patent/RU2193030C2/ru not_active IP Right Cessation
- 1997-12-09 PL PL97334370A patent/PL188945B1/pl not_active IP Right Cessation
- 1997-12-09 HU HU0000613A patent/HUP0000613A3/hu unknown
- 1997-12-09 CN CNB971808376A patent/CN1154635C/zh not_active Expired - Fee Related
- 1997-12-09 ID IDW990536A patent/ID21662A/id unknown
- 1997-12-09 SK SK763-99A patent/SK283300B6/sk unknown
- 1997-12-09 CN CNA2004100324204A patent/CN1539824A/zh active Pending
- 1997-12-09 PT PT97950539T patent/PT946510E/pt unknown
- 1997-12-09 KR KR1019997005586A patent/KR20000069600A/ko not_active Ceased
- 1997-12-09 JP JP52867098A patent/JP2001507021A/ja not_active Ceased
- 1997-12-09 US US09/029,468 patent/US6153626A/en not_active Expired - Lifetime
- 1997-12-09 EP EP97950539A patent/EP0946510B1/en not_active Expired - Lifetime
- 1997-12-09 WO PCT/SE1997/002051 patent/WO1998028270A1/en not_active Ceased
- 1997-12-09 EP EP04002901A patent/EP1428821A1/en not_active Withdrawn
- 1997-12-09 DE DE69729115T patent/DE69729115T2/de not_active Expired - Fee Related
- 1997-12-09 ES ES97950539T patent/ES2219783T3/es not_active Expired - Lifetime
- 1997-12-09 CA CA002274117A patent/CA2274117A1/en not_active Abandoned
- 1997-12-09 IL IL13053697A patent/IL130536A0/xx unknown
- 1997-12-09 EE EEP199900261A patent/EE03966B1/xx not_active IP Right Cessation
- 1997-12-19 MY MYPI97006174A patent/MY132705A/en unknown
- 1997-12-19 AR ARP970106076A patent/AR010378A1/es active IP Right Grant
1999
- 1999-06-11 IS IS5078A patent/IS5078A/is unknown
- 1999-06-18 NO NO19993023A patent/NO313632B1/no unknown
2000
- 2000-08-25 US US09/645,565 patent/US6399635B1/en not_active Expired - Fee Related
2002
- 2002-04-15 US US10/121,683 patent/US6710179B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69729115T2 (de)	2005-04-28
EE9900261A (et)	2000-02-15
EP0946510A1 (en)	1999-10-06
KR20000069600A (ko)	2000-11-25
UA54481C2 (uk)	2003-03-17
HK1023996A1 (en)	2000-09-29
PT946510E (pt)	2004-08-31
EP1428821A8 (en)	2005-01-26
AU738002B2 (en)	2001-09-06
CN1539824A (zh)	2004-10-27
SK76399A3 (en)	2000-01-18
CA2274117A1 (en)	1998-07-02
CN1154635C (zh)	2004-06-23
RU2193030C2 (ru)	2002-11-20
US6399635B1 (en)	2002-06-04
ATE266638T1 (de)	2004-05-15
SK283300B6 (sk)	2003-05-02
MY132705A (en)	2007-10-31
US6710179B2 (en)	2004-03-23
HUP0000613A2 (hu)	2000-09-28
JP2001507021A (ja)	2001-05-29
NO313632B1 (no)	2002-11-04
SE9604786D0 (sv)	1996-12-20
EE03966B1 (et)	2003-02-17
PL188945B1 (pl)	2005-05-31
ID21662A (id)	1999-07-08
DK0946510T3 (da)	2004-08-09
HK1022910A1 (en)	2000-08-25
ES2219783T3 (es)	2004-12-01
ZA9711049B (en)	1998-06-22
AR010378A1 (es)	2000-06-07
NO993023D0 (no)	1999-06-18
NZ336028A (en)	2001-03-30
IL130536A0 (en)	2000-06-01
US20030055045A1 (en)	2003-03-20
WO1998028270A1 (en)	1998-07-02
CN1241178A (zh)	2000-01-12
CZ220099A3 (cs)	1999-11-17
DE69729115D1 (de)	2004-06-17
TR199901411T2 (xx)	1999-09-21
US6153626A (en)	2000-11-28
HUP0000613A3 (en)	2002-10-28
NO993023L (no)	1999-08-12
EP0946510B1 (en)	2004-05-12
PL334370A1 (en)	2000-02-28
AU5351398A (en)	1998-07-17
BR9713785A (pt)	2000-02-08
EP1428821A1 (en)	2004-06-16

Publication	Publication Date	Title
IS5071A (is)	1999-06-07	Ný efnasambönd með verkjadeyfandi áhrif
IS5078A (is)	1999-06-11	Ný efnasambönd með verkjadeyfandi áhrif
PT799819E (pt)	2003-01-31	Compostos de 1-dimetilaminometil-2-fenilcicloalc-2-eno com efeito analgesico
EE9800194A (et)	1998-12-15	Uued valuvaigistava toimega ühendid
FI964576A7 (fi)	1996-11-15	Uusia agonistiyhdisteitä
BR9710352A (pt)	1999-08-17	Compostos piridilpirrole
ATE253919T1 (de)	2003-11-15	Analgetika-kombination
EE9800430A (et)	1999-06-15	Uued ühendid
BR9705635A (pt)	1999-05-18	Compostos
EE9800195A (et)	1998-12-15	Uudsed analgeetilise toimega ühendid
EP0926953A4 (en)	1999-10-13	HALOPROPARGYL INCLUDING COMPOUNDS
IS4932A (is)	1998-12-23	Ný efnasambönd
DK1019042T3 (da)	2003-08-25	Forbindelser med anti-første-passagevirkning
DK0946511T3 (da)	2005-08-22	Hidtil ukendte forbindelser med analgesisk virkning
SE9603464D0 (sv)	1996-09-23	New compounds
SE9604785D0 (sv)	1996-12-20	New compounds
SE9603505D0 (sv)	1996-09-25	New compounds
SE9604787D0 (sv)	1996-12-20	New compounds
SE9603470D0 (sv)	1996-09-23	New compounds
SE9604788D0 (sv)	1996-12-20	New compounds
SE9601787D0 (sv)	1996-05-10	New compounds
SE9600555D0 (sv)	1996-02-15	New compounds
SE9600554D0 (sv)	1996-02-15	New compounds
SI0946511T1 (en)	2005-10-31	Novel compounds with analgesic effect
SI0946510T1 (en)	2004-12-31	Novel compounds with analgesic effect